Patient Registry Software Market by Type of Registry (Diabetes, Cancer, Rare Disease, Asthma, Kidney), Software (Integrated and Standalone), Delivery (On Premise and Cloud), Pricing Model, Database (Public), End User (Hospitals)- Global Industry Analysis, Share, Growth, Regional Outlook and Forecasts, 2021-2027

The global Patient Registry Software market gathered revenue around USD 1.9 Billion in 2020 and market is set to grow USD 4.0 Billion by the end of 2027 and is estimated to expand at a modest CAGR of 16.2% during the prediction period 2021 to 2027.

Patient Registry Software Market Size 2020 to 2027

Growth Factors:

The growth of this market is mainly attributed to the shift toward computerized registries to provide users with an automated way to store data and create, sort, and display patient lists for use in planning, quality improvement, reporting, and direct care delivery. Also, the emergence of the COVID-19 pandemic and the increasing number of COVID-19 patients globally are expected to increase the demand for patient registry software in the coming years. Vendors are using organic growth strategies such as product launches and innovations, which has resulted into an increasing availability of advanced products globally.  

However, shortage of trained and skilled resources and privacy and data security related concerns are expected to restrain the growth of this market during the forecast period.

This research report purposes at stressing the most lucrative growth prospects. The aim of the research report is to provide an inclusive valuation of the Patient Registry Software market and it encompasses thoughtful visions, actualities, industry-validated market findings, historic data, and prognoses by means of appropriate set of assumptions and practice. Global Patient Registry Software market report aids in comprehending market structure and dynamics by recognizing and scrutinizing the market sectors and predicted the global market outlook.

Report Coverage

Report Scope Details
Market Size USD 4.0 Billion by 2027
Growth Rate CAGR of 16.2% From 2021 to 2027
Base Year 2020
Forecast Period 2021 to 2027
Historic Data 2017 to 2020
Report coverage Growth Factors, Revenue Status, Competitive Landscape,  and Future Trends
Segments Covered Types of Registry, Types of Software, Pricing Model, Deployment Model, Types of Database, Functionality, End User and Region
Regional Scope North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA)
Companies Mentioned Phytel, Inc.; McKesson Corporation; Quintiles; Dacima Software Inc.; ImageTrend, Inc.; IBM; IQVIA. Syneos Health , ESO Solutions.

COVID-19 Impact Assessment on Market Landscape

The report comprises the scrutiny of COVID-19 lock-down impact on the income of market leaders, disrupters and followers. Since lock down was instigated differently in diverse regions and nations, influence of same is also dissimilar across various industry verticals. The research report offers present short-term and long-term influence on the market to assist market participants across value chain makers to formulate the framework for short term and long-lasting tactics for recovery and by region.

Patient Registry Software market Report empowers readers with all-inclusive market intelligence and offers a granular outline of the market they are operational in. Further this research study delivers exceptional combination of tangible perceptions and qualitative scrutiny to aid companies accomplishes sustainable growth. This report employs industry-leading research practices and tools to assemble all-inclusive market studies, intermingled with pertinent data. Additionally, this report also emphases on the competitive examination of crucial players by analyzing their product portfolio, pricing, gross margins, financial position, growth approaches, and regional occurrence.

Challenges analysis:

The continued use of existing paper-based and unorganized computer-based registry tools is restricting the implementation of advanced HCIT solutions, such as patient registry solutions, especially in developing countries. Many hospitals and physicians, particularly in small and rural areas, continue to rely on basic existing methods such as spreadsheets or case paper-based patient registry methods. These tools are only used at the department level, with retrospective data. In this approach, reports are considered as being good for a specific period until they become too inefficient to continue. Furthermore, many hospitals and other end users are opposed to adopting advanced EHR systems and patient registry software due to the costs associated with the software purchase and implementation, coupled with the lack of operating skills for these advanced tools.

Regional analysis:

North America dominated the global market for patient registry software in terms of revenue share in 2019. Increasing target population coupled with rising prevalence of diseases and need for population-based registries are propelling the growth of the market in this region. Moreover, increasing government initiatives make this region as a major contributor to the market for patient registry software. In order to make patient registry software more user interactive and clinical research-friendly, companies are constantly trying to develop better user-interactive software. For instance, in August 2020, IQVIA launched a new web-based solution for the enrollment of clinical trial information.

Asia Pacific is expected to show lucrative growth over the forecast period. Adoption of electronic medical records has been increasing over the past few years. Rising pressure to curb medical errors, repeated hospital visits, increased diagnostics errors coupled with rising incidences of co-morbidities, and the aging population are major factors driving the market in the region. Furthermore, supportive government initiatives, especially in Japan, China, and South Korea are boosting the growth of the market for patient registry software. For instance, in May 2019, the South Korean Government invested USD 35.2 Million to expand the artificial intelligence system that will intend to analyze a patient’s medical registry for better diagnostics and treatment options. Fujifilm established FUJIFILM VET Systems in Japan in 2020 in order to penetrate the regional cancer registry software market.

Competitive Rivalry

Foremost players in the market are attentive on adopting corporation strategies to enhance their market share. Some of the prominent tactics undertaken by leading market participants in order to sustain the fierce market completion include collaborations, acquisitions, substantial spending in R&D and the improvement of new-fangled products or reforms among others.

Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.

  • Company Overview
  • Company Market Share/Positioning Analysis
  • Product Offerings
  • Financial Performance
  • Recent Initiatives
  • Key Strategies Adopted by Players
  • Vendor Landscape
  • List of Suppliers
  • List of Buyers

Some of the prominent players in the Patient Registry Software Market include:  Phytel, Inc.; McKesson Corporation; Quintiles; Dacima Software Inc.; ImageTrend, Inc.; IBM; IQVIA. Syneos Health , ESO Solutions.

Unravelling the Critical Segments

This research report offers market revenue, sales volume, production assessment and prognoses by classifying it on the basis of various aspects including product type, application/end-user, and region. Further, this research study investigates market size, production, consumption and its development trends at global, regional, and country level for period 2017 to 2027 and covers subsequent region in its scope:

Global Patient Registry Software Market, by Types of Registry

  • Patient Registry Software Market, By Type of Registry
    •  Introduction
    •  Disease Registry
      • Diabetes Registries
      • Cardiovascular Registries
      •   Cancer Registries
      •   Rare Disease Registries
      •   Asthma Registries
      •   Chronic Kidney Registries
      •   Orthopedic Registries
      •   Other Disease Registries
    •  Health Service Registeries
    •  Product Registeries
      •   Medical Device Registries
      •   Drug  Registries

Patient Registry Software Market, By Type of Software

  • Patient Registry Software Market, By Type of Software
    •  Introduction
    •  Integrated Software

Patient Registry Software Market, By Pricing Model

  • Patient Registry Software Market, By Pricing Model
    •  Introduction
    •  Subscription Model;
    •  Ownership Model

Patient Registry Software Market, By Deployment Model

  • Patient Registry Software Market, By Deployment Model
    •  Introduction
    •  On-Premise Model
    •  Cloud-Based Model

Patient Registry Software Market, By Type of Database

  • Patient Registry Software Market, By Type of Database
    •  Introduction
    •  Commercial Database
    •  Public Database

Patient Registry Software Market, By Functionality

  • Patient Registry Software Market, By Functionality
    •  Introduction
    •  Population Health Management
    •  Patient Care Management
    •  Medical Research & Clinical Studies
    •  Health Information Exchange
    •  Point-of-Care
    •  Product Outcome Evaluation

Patient Registry Software Market, By End User

  • Patient Registry Software Market, By End User
    •  Introduction
    •  Government Organizations and Third-Party Administrators;
    •  Hospitals & Medical Practices
    •  Private Payers
    •  Pharmaceutical, Biotechnology, and Medical Device Companies
    •  Research Centers

By Geography

North America

  • U.S.
  • Canada

Europe

  • Germany
  • France
  • United Kingdom
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Southeast Asia
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Rest of Latin America

Middle East & Africa (MEA)

  • GCC
  • North Africa
  • South Africa
  • Rest of Middle East & Africa

Highlights of the Report:

  • Market Penetration: Comprehensive information on the product portfolios of the top players in the market.
  • Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and product launches in the market
  • Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the market
  • Market Development: Comprehensive information about emerging markets. This report analyzes the market for various segments across geographies
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the market

Research Methodology

In the study, a unique research methodology is utilized to conduct extensive research on the growth of the Patient Registry Software market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure the accuracy and reliability of the conclusions.

Secondary resources referred to by analysts during the production of the Patient Registry Software market study are as follows - statistics from government organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, all of whom have contributed to the development of this report as a primary resource.

Comprehensive information acquired from primary and secondary resources acts as a validation from companies in the market, and makes the projections on the growth prospects of the Patient Registry Software markets more accurate and reliable.

Secondary Research

It involves company databases such as Hoover's: This assists us recognize financial information, structure of the market participants and industry competitive landscape.

The secondary research sources referred in the process are as follows:

  • Governmental bodies, and organizations creating economic policies
  • National and international social welfare institutions
  • Company websites, financial reports and SEC filings, broker and investor reports
  • Related patent and regulatory databases
  • Statistical databases and market reports
  • Corporate Presentations, news, press release, and specification sheet of Manufacturers

Primary Research

Primary research includes face-to face interviews, online surveys, and telephonic interviews.

  • Means of primary research: Email interactions, telephonic discussions and Questionnaire based research etc.
  • In order to validate our research findings and analysis we conduct primary interviews of key industry participants. Insights from primary respondents help in validating the secondary research findings. It also develops Research Team’s expertise and market understanding.

Industry participants involved in this research study include:

  • CEOs, VPs, market intelligence managers
  • Procuring and national sales managers technical personnel, distributors and resellers
  • Research analysts and key opinion leaders from various domains

Key Points Covered in Patient Registry Software market Study:

 

  • Growth of Patient Registry Software in 2021
  • Market Estimates and Forecasts (2017-2027)
  •  Brand Share and Market Share Analysis
  •  Key Drivers and Restraints Shaping Market Growth
  •  Segment-wise, Country-wise, and Region-wise Analysis
  •  Competition Mapping and Benchmarking
  •  Recommendation on Key Winning Strategies
  •  COVID-19 Impact on Demand for Patient Registry Software and How to Navigate
  •  Key Product Innovations and Regulatory Climate
  •  Patient Registry Software Consumption Analysis
  •  Patient Registry Software Production Analysis
  •  Patient Registry Software and Management

 

Growth Factors:

The growth of this market is mainly attributed to the shift toward computerized registries to provide users with an automated way to store data and create, sort, and display patient lists for use in planning, quality improvement, reporting, and direct care delivery. Also, the emergence of the COVID-19 pandemic and the increasing number of COVID-19 patients globally are expected to increase the demand for patient registry software in the coming years. Vendors are using organic growth strategies such as product launches and innovations, which has resulted into an increasing availability of advanced products globally.  

However, shortage of trained and skilled resources and privacy and data security related concerns are expected to restrain the growth of this market during the forecast period.

This research report purposes at stressing the most lucrative growth prospects. The aim of the research report is to provide an inclusive valuation of the Patient Registry Software market and it encompasses thoughtful visions, actualities, industry-validated market findings, historic data, and prognoses by means of appropriate set of assumptions and practice. Global Patient Registry Software market report aids in comprehending market structure and dynamics by recognizing and scrutinizing the market sectors and predicted the global market outlook.

Report Coverage

COVID-19 Impact Assessment on Market Landscape

The report comprises the scrutiny of COVID-19 lock-down impact on the income of market leaders, disrupters and followers. Since lock down was instigated differently in diverse regions and nations, influence of same is also dissimilar across various industry verticals. The research report offers present short-term and long-term influence on the market to assist market participants across value chain makers to formulate the framework for short term and long-lasting tactics for recovery and by region.

Patient Registry Software market Report empowers readers with all-inclusive market intelligence and offers a granular outline of the market they are operational in. Further this research study delivers exceptional combination of tangible perceptions and qualitative scrutiny to aid companies accomplishes sustainable growth. This report employs industry-leading research practices and tools to assemble all-inclusive market studies, intermingled with pertinent data. Additionally, this report also emphases on the competitive examination of crucial players by analyzing their product portfolio, pricing, gross margins, financial position, growth approaches, and regional occurrence.

Challenges analysis:

The continued use of existing paper-based and unorganized computer-based registry tools is restricting the implementation of advanced HCIT solutions, such as patient registry solutions, especially in developing countries. Many hospitals and physicians, particularly in small and rural areas, continue to rely on basic existing methods such as spreadsheets or case paper-

Chapter 1.    Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.    Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.    Executive Summary

3.1.  Market Snapshot

Chapter 4.    Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.     Raw Material Procurement Analysis

4.3.2.     Sales and Distribution Channel Analysis

4.3.3.     Downstream Buyer Analysis

Chapter 5.    Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.     Market Drivers

5.1.2.     Market Restraints

5.1.3.     Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.     Bargaining power of suppliers

5.2.2.     Bargaining power of buyers

5.2.3.     Threat of substitute

5.2.4.     Threat of new entrants

5.2.5.     Degree of competition

Chapter 6.    Competitive Landscape

6.1.1.     Company Market Share/Positioning Analysis

6.1.2.     Key Strategies Adopted by Players

6.1.3.     Vendor Landscape

6.1.3.1.          List of Suppliers

6.1.3.2.          List of Buyers

Chapter 7.    Global Patient Registry Software Market, By Types of Registry

7.1.  Patient Registry Software Market, by Types of Registry, 2021-2027

7.1.1.     Introduction

7.1.1.1.          Market Revenue and Forecast (2016-2027)

7.1.2.     Disease Registry

7.1.2.1.          Market Revenue and Forecast (2016-2027)

7.1.3.     Health Service Registeries

7.1.3.1.          Market Revenue and Forecast (2016-2027)

7.1.4.     Product Registeries

7.1.4.1.          Market Revenue and Forecast (2016-2027)

Chapter 8.    Global Patient Registry Software Market, By Type of Software

8.1.  Patient Registry Software Market, By Type of Software, 2021-2027

8.1.1.     Introduction

8.1.1.1.          Market Revenue and Forecast (2016-2027)

8.1.2.     Integrated Software

8.1.2.1.          Market Revenue and Forecast (2016-2027)

Chapter 9.    Global Patient Registry Software Market, By Pricing Model

9.1.  Patient Registry Software Market, By Pricing Model, 2021-2027

9.1.1.     Introduction

9.1.1.1.          Market Revenue and Forecast (2016-2027)

9.1.2.     Subscription Model

9.1.2.1.          Market Revenue and Forecast (2016-2027)

9.1.3.     Ownership Model

9.1.3.1.          Market Revenue and Forecast (2016-2027)

Chapter 10.Global Patient Registry Software  Market, By Deployment Model

10.1.          Patient Registry Software Market, By Deployment Model, 2021-2027

10.1.1.  Introduction

10.1.1.1.       Market Revenue and Forecast (2016-2027)

10.1.2.  On-Premise Model

10.1.2.1.       Market Revenue and Forecast (2016-2027)

10.1.3.  Cloud-Based Model

10.1.3.1.       Market Revenue and Forecast (2016-2027)

Chapter 11.Global Patient Registry Software  Market, By Type of Database

11.1.          Patient Registry Software  Market, By Type of Database, 2021-2027

11.1.1.  Introduction

11.1.1.1.       Market Revenue and Forecast (2016-2027)

11.1.2.  Commercial Database

11.1.2.1.       Market Revenue and Forecast (2016-2027)

11.1.3.  Public Database

11.1.3.1.       Market Revenue and Forecast (2016-2027)

Chapter 12.Global Patient Registry Software  Market, By Functionality

12.1.          Patient Registry Software  Market, By Functionality, 2021-2027

12.1.1.  Introduction

12.1.1.1.       Market Revenue and Forecast (2016-2027)

12.1.2.  Population Health Management

12.1.2.1.       Market Revenue and Forecast (2016-2027)

12.1.3.  Population Health Management

12.1.3.1.       Market Revenue and Forecast (2016-2027)

12.1.4.  Medical Research & Clinical Studies

12.1.4.1.       Market Revenue and Forecast (2016-2027)

12.1.5.  Health Information Exchange

12.1.5.1.       Market Revenue and Forecast (2016-2027)

12.1.6.  Point-of-Care

12.1.6.1.       Market Revenue and Forecast (2016-2027)

12.1.7.  Product Outcome Evaluation

12.1.7.1.       Market Revenue and Forecast (2016-2027)

Chapter 13.Global Patient Registry Software  Market, By End User

13.1.          Patient Registry Software Market, By End User, 2021-2027

13.1.1.  Introduction

13.1.1.1.       Market Revenue and Forecast (2016-2027)

13.1.2.  Government Organizations and Third-Party Administrators

13.1.2.1.       Market Revenue and Forecast (2016-2027)

13.1.3.  Hospitals & Medical Practices

13.1.3.1.       Market Revenue and Forecast (2016-2027)

13.1.4.  Private Payers

13.1.4.1.       Market Revenue and Forecast (2016-2027)

13.1.5.  Pharmaceutical, Biotechnology, and Medical Device Companies

13.1.5.1.       Market Revenue and Forecast (2016-2027)

13.1.6.  Research Centers

13.1.6.1.       Market Revenue and Forecast (2016-2027)

Chapter 14.Global Patient Registry Software Market, Regional Estimates and Trend Forecast

14.1.          North America

14.1.1.  Market Revenue and Forecast, by Types of Registry (2016-2027)

14.1.2.  Market Revenue and Forecast, By Type of Software (2016-2027)

14.1.3.  Market Revenue and Forecast, By Pricing Model (2016-2027)

14.1.4.  Market Revenue and Forecast, By Deployment Model (2016-2027)

14.1.5.  Market Revenue and Forecast, By Type of Database (2016-2027)

14.1.6.  Market Revenue and Forecast, By End User (2016-2027)

14.1.7.  Market Revenue and Forecast, By Functionality (2016-2027)

14.1.8.  U.S.

14.1.8.1.       Market Revenue and Forecast, by Types of Registry (2016-2027)

14.1.8.2.       Market Revenue and Forecast, By Type of Software (2016-2027)

14.1.8.3.       Market Revenue and Forecast, By Pricing Model (2016-2027)

14.1.8.4.       Market Revenue and Forecast, By Deployment Model (2016-2027)

14.1.8.5.       Market Revenue and Forecast, By Type of Database (2016-2027)

14.1.8.6.       Market Revenue and Forecast, By End User (2016-2027)

14.1.8.7.       Market Revenue and Forecast, By Functionality (2016-2027)

14.1.9.  Rest of North America

14.1.9.1.       Market Revenue and Forecast, by Types of Registry (2016-2027)

14.1.9.2.       Market Revenue and Forecast, By Type of Software (2016-2027)

14.1.9.3.       Market Revenue and Forecast, By Pricing Model (2016-2027)

14.1.9.4.       Market Revenue and Forecast, By Deployment Model (2016-2027)

14.1.9.5.       Market Revenue and Forecast, By Type of Database (2016-2027)

14.1.9.6.       Market Revenue and Forecast, By End User (2016-2027)

14.1.9.7.       Market Revenue and Forecast, By Functionality (2016-2027)

14.2.          Europe

14.2.1.  Market Revenue and Forecast, by Types of Registry (2016-2027)

14.2.2.  Market Revenue and Forecast, By Type of Software (2016-2027)

14.2.3.  Market Revenue and Forecast, By Pricing Model (2016-2027)

14.2.4.  Market Revenue and Forecast, By Deployment Model (2016-2027)

14.2.5.  Market Revenue and Forecast, By Type of Database (2016-2027)

14.2.6.  Market Revenue and Forecast, By End User (2016-2027)

14.2.7.  Market Revenue and Forecast, By Functionality (2016-2027)

14.2.8.  UK

14.2.8.1.       Market Revenue and Forecast, by Types of Registry (2016-2027)

14.2.8.2.       Market Revenue and Forecast, By Type of Software (2016-2027)

14.2.8.3.       Market Revenue and Forecast, By Pricing Model (2016-2027)

14.2.8.4.       Market Revenue and Forecast, By Deployment Model (2016-2027)

14.2.8.5.       Market Revenue and Forecast, By Type of Database (2016-2027)

14.2.8.6.       Market Revenue and Forecast, By End User (2016-2027)

14.2.8.7.       Market Revenue and Forecast, By Functionality (2016-2027)

14.2.9.  Germany

14.2.9.1.       Market Revenue and Forecast, by Types of Registry (2016-2027)

14.2.9.2.       Market Revenue and Forecast, By Type of Software (2016-2027)

14.2.9.3.       Market Revenue and Forecast, By Pricing Model (2016-2027)

14.2.9.4.       Market Revenue and Forecast, By Deployment Model (2016-2027)

14.2.9.5.       Market Revenue and Forecast, By Type of Database (2016-2027)

14.2.9.6.       Market Revenue and Forecast, By End User (2016-2027)

14.2.9.7.       Market Revenue and Forecast, By Functionality (2016-2027)

14.2.10.                   France

14.2.10.1.    Market Revenue and Forecast, by Types of Registry (2016-2027)

14.2.10.2.    Market Revenue and Forecast, By Type of Software (2016-2027)

14.2.10.3.    Market Revenue and Forecast, By Pricing Model (2016-2027)

14.2.10.4.    Market Revenue and Forecast, By Deployment Model (2016-2027)

14.2.10.5.    Market Revenue and Forecast, By Type of Database (2016-2027)

14.2.10.6.    Market Revenue and Forecast, By End User (2016-2027)

14.2.10.7.    Market Revenue and Forecast, By Functionality (2016-2027)

14.2.11.                   Rest of Europe

14.2.11.1.    Market Revenue and Forecast, by Types of Registry (2016-2027)

14.2.11.2.    Market Revenue and Forecast, By Type of Software (2016-2027)

14.2.11.3.    Market Revenue and Forecast, By Pricing Model (2016-2027)

14.2.11.4.    Market Revenue and Forecast, By Deployment Model (2016-2027)

14.2.11.5.    Market Revenue and Forecast, By Type of Database (2016-2027)

14.2.11.6.    Market Revenue and Forecast, By End User (2016-2027)

14.2.11.7.    Market Revenue and Forecast, By Functionality (2016-2027)

14.3.          APAC

14.3.1.  Market Revenue and Forecast, by Types of Registry (2016-2027)

14.3.2.  Market Revenue and Forecast, By Type of Software (2016-2027)

14.3.3.  Market Revenue and Forecast, By Pricing Model (2016-2027)

14.3.4.  Market Revenue and Forecast, By Deployment Model (2016-2027)

14.3.5.  Market Revenue and Forecast, By Type of Database (2016-2027)

14.3.6.  Market Revenue and Forecast, By End User (2016-2027)

14.3.7.  Market Revenue and Forecast, By Functionality (2016-2027)

14.3.8.  India

14.3.8.1.       Market Revenue and Forecast, by Types of Registry (2016-2027)

14.3.8.2.       Market Revenue and Forecast, By Type of Software (2016-2027)

14.3.8.3.       Market Revenue and Forecast, By Pricing Model (2016-2027)

14.3.8.4.       Market Revenue and Forecast, By Deployment Model (2016-2027)

14.3.8.5.       Market Revenue and Forecast, By Type of Database (2016-2027)

14.3.8.6.       Market Revenue and Forecast, By End User (2016-2027)

14.3.8.7.       Market Revenue and Forecast, By Functionality (2016-2027)

14.3.9.  China

14.3.9.1.       Market Revenue and Forecast, by Types of Registry (2016-2027)

14.3.9.2.       Market Revenue and Forecast, By Type of Software (2016-2027)

14.3.9.3.       Market Revenue and Forecast, By Pricing Model (2016-2027)

14.3.9.4.       Market Revenue and Forecast, By Deployment Model (2016-2027)

14.3.9.5.       Market Revenue and Forecast, By Type of Database (2016-2027)

14.3.9.6.       Market Revenue and Forecast, By End User (2016-2027)

14.3.9.7.       Market Revenue and Forecast, By Functionality (2016-2027)

14.3.10.                   Japan

14.3.10.1.    Market Revenue and Forecast, by Types of Registry (2016-2027)

14.3.10.2.    Market Revenue and Forecast, By Type of Software (2016-2027)

14.3.10.3.    Market Revenue and Forecast, By Pricing Model (2016-2027)

14.3.10.4.    Market Revenue and Forecast, By Deployment Model (2016-2027)

14.3.10.5.    Market Revenue and Forecast, By Type of Database (2016-2027)

14.3.10.6.    Market Revenue and Forecast, By End User (2016-2027)

14.3.10.7.    Market Revenue and Forecast, By Functionality (2016-2027)

14.3.11.                   Rest of APAC

14.3.11.1.    Market Revenue and Forecast, by Types of Registry (2016-2027)

14.3.11.2.    Market Revenue and Forecast, By Type of Software (2016-2027)

14.3.11.3.    Market Revenue and Forecast, By Pricing Model (2016-2027)

14.3.11.4.    Market Revenue and Forecast, By Deployment Model (2016-2027)

14.3.11.5.    Market Revenue and Forecast, By Type of Database (2016-2027)

14.3.11.6.    Market Revenue and Forecast, By End User (2016-2027)

14.3.11.7.    Market Revenue and Forecast, By Functionality (2016-2027)

14.4.          MEA

14.4.1.  Market Revenue and Forecast, by Types of Registry (2016-2027)

14.4.2.  Market Revenue and Forecast, By Type of Software (2016-2027)

14.4.3.  Market Revenue and Forecast, By Pricing Model (2016-2027)

14.4.4.  Market Revenue and Forecast, By Deployment Model (2016-2027)

14.4.5.  Market Revenue and Forecast, By Type of Database (2016-2027)

14.4.6.  Market Revenue and Forecast, By End User (2016-2027)

14.4.7.  Market Revenue and Forecast, By Functionality (2016-2027)

14.4.8.  GCC

14.4.8.1.       Market Revenue and Forecast, by Types of Registry (2016-2027)

14.4.8.2.       Market Revenue and Forecast, By Type of Software (2016-2027)

14.4.8.3.       Market Revenue and Forecast, By Pricing Model (2016-2027)

14.4.8.4.       Market Revenue and Forecast, By Deployment Model (2016-2027)

14.4.8.5.       Market Revenue and Forecast, By Type of Database (2016-2027)

14.4.8.6.       Market Revenue and Forecast, By End User (2016-2027)

14.4.8.7.       Market Revenue and Forecast, By Functionality (2016-2027)

14.4.9.  North Africa

14.4.9.1.       Market Revenue and Forecast, by Types of Registry (2016-2027)

14.4.9.2.       Market Revenue and Forecast, By Type of Software (2016-2027)

14.4.9.3.       Market Revenue and Forecast, By Pricing Model (2016-2027)

14.4.9.4.       Market Revenue and Forecast, By Deployment Model (2016-2027)

14.4.9.5.       Market Revenue and Forecast, By Type of Database (2016-2027)

14.4.9.6.       Market Revenue and Forecast, By End User (2016-2027)

14.4.9.7.       Market Revenue and Forecast, By Functionality (2016-2027)

14.4.10.                   South Africa

14.4.10.1.    Market Revenue and Forecast, by Types of Registry (2016-2027)

14.4.10.2.    Market Revenue and Forecast, By Type of Software (2016-2027)

14.4.10.3.    Market Revenue and Forecast, By Pricing Model (2016-2027)

14.4.10.4.    Market Revenue and Forecast, By Deployment Model (2016-2027)

14.4.10.5.    Market Revenue and Forecast, By Type of Database (2016-2027)

14.4.10.6.    Market Revenue and Forecast, By End User (2016-2027)

14.4.10.7.    Market Revenue and Forecast, By Functionality (2016-2027)

14.4.11.                   Rest of MEA

14.4.11.1.    Market Revenue and Forecast, by Types of Registry (2016-2027)

14.4.11.2.    Market Revenue and Forecast, By Type of Software (2016-2027)

14.4.11.3.    Market Revenue and Forecast, By Pricing Model (2016-2027)

14.4.11.4.    Market Revenue and Forecast, By Deployment Model (2016-2027)

14.4.11.5.    Market Revenue and Forecast, By Type of Database (2016-2027)

14.4.11.6.    Market Revenue and Forecast, By End User (2016-2027)

14.4.11.7.    Market Revenue and Forecast, By Functionality (2016-2027)

14.5.          Latin America

14.5.1.  Market Revenue and Forecast, by Types of Registry (2016-2027)

14.5.2.  Market Revenue and Forecast, By Type of Software (2016-2027)

14.5.3.  Market Revenue and Forecast, By Pricing Model (2016-2027)

14.5.4.  Market Revenue and Forecast, By Deployment Model (2016-2027)

14.5.5.  Market Revenue and Forecast, By Type of Database (2016-2027)

14.5.6.  Market Revenue and Forecast, By End User (2016-2027)

14.5.7.  Market Revenue and Forecast, By Functionality (2016-2027)

14.5.8.  Brazil

14.5.8.1.       Market Revenue and Forecast, by Types of Registry (2016-2027)

14.5.8.2.       Market Revenue and Forecast, By Type of Software (2016-2027)

14.5.8.3.       Market Revenue and Forecast, By Pricing Model (2016-2027)

14.5.8.4.       Market Revenue and Forecast, By Deployment Model (2016-2027)

14.5.8.5.       Market Revenue and Forecast, By Type of Database (2016-2027)

14.5.8.6.       Market Revenue and Forecast, By End User (2016-2027)

14.5.8.7.       Market Revenue and Forecast, By Functionality (2016-2027)

14.5.9.  Rest of LATAM

14.5.9.1.       Market Revenue and Forecast, by Types of Registry (2016-2027)

14.5.9.2.       Market Revenue and Forecast, By Type of Software (2016-2027)

14.5.9.3.       Market Revenue and Forecast, By Pricing Model (2016-2027)

14.5.9.4.       Market Revenue and Forecast, By Deployment Model (2016-2027)

14.5.9.5.       Market Revenue and Forecast, By Type of Database (2016-2027)

14.5.9.6.       Market Revenue and Forecast, By End User (2016-2027)

14.5.9.7.       Market Revenue and Forecast, By Functionality (2016-2027)

Chapter 15.   Company Profiles

15.1.                 Phytel, Inc

15.1.1.  Company Overview

15.1.2.  Product Offerings

15.1.3.  Financial Performance

15.1.4.  Recent Initiatives

15.2.                 McKesson Corporation

15.2.1.  Company Overview

15.2.2.  Product Offerings

15.2.3.  Financial Performance

15.2.4.  Recent Initiatives

15.3.                 Quintiles

15.3.1.  Company Overview

15.3.2.  Product Offerings

15.3.3.  Financial Performance

15.3.4.  Recent Initiatives

15.4.                 Dacima Software Inc

15.4.1.  Company Overview

15.4.2.  Product Offerings

15.4.3.  Financial Performance

15.4.4.  Recent Initiatives

15.5.                 ImageTrend, Inc

15.5.1.  Company Overview

15.5.2.  Product Offerings

15.5.3.  Financial Performance

15.5.4.  Recent Initiatives

15.6.                 IBM

15.6.1.  Company Overview

15.6.2.  Product Offerings

15.6.3.  Financial Performance

15.6.4.  Recent Initiatives

15.7.                 IQVIA

15.7.1.  Company Overview

15.7.2.  Product Offerings

15.7.3.  Financial Performance

15.7.4.  Recent Initiatives

15.8.                 Syneos Health 

15.8.1.  Company Overview

15.8.2.  Product Offerings

15.8.3.  Financial Performance

15.8.4.  Recent Initiatives

15.9.                 ESO Solutions

15.9.1.  Company Overview

15.9.2.  Product Offerings

15.9.3.  Financial Performance

15.9.4.  Recent Initiatives

Chapter 16.   Research Methodology

16.1.                 Primary Research

16.2.                 Secondary Research

16.3.                 Assumptions

Chapter 17.   Appendix

17.1.                 About Us

17.2.                 Glossary of Terms

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers
Ask To Expert